IND approval
Scope
Date
~
-
Mergers & Acquisitions
Korean Air may give up Asiana’s cargo business, 4 routes for EU approval
Korean Air Lines Co. may give up the cargo business of Asiana Airlines Inc. and four of its lucrative routes in Europe in an all-in bet as the marri...
Sep 25, 2023 (Gmt+09:00)
-
Energy
Land use for SK Ecoplant's wind power venture in Canada approved
The green hydrogen Nujio’qonik project in Canada, a venture that South Korea's SK Ecoplant is taking part in, has secured approval to use go...
Sep 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Hugel resubmits application to FDA for botulinum toxin product
South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...
Sep 01, 2023 (Gmt+09:00)
-
Energy
Hyundai Steel's offshore wind power plant gets int’l certification
South Korea’s Hyundai Steel on Wednesday said its Ulsan Factory 2 in the southern coastal city of Ulsan received certification as an offshore ...
Aug 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
SM Korealine gets self-sailing approval from Panama
SM Korealine Co., a unit of SM Group's maritime division, announced on Monday that its subsidiary Korealine LNG, has obtained approval for self-sail...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Energy
Poland kicks off approval process to import S.Korean reactors
Poland has started an approval process to build a nuclear power plant consisting of South Korean reactors, according to foreign media reports, despi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CGBio gets FDA approval for spinal implant
CGBio, a South Korean bio-regenerative medical company, announced on Monday that its "Advanced LumFix spinal fixation system," an implant and surgic...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Earnings
KT earnings beat estimates in Q2; shares hit 6-month high
KT Corp., South Korea’s leading telecommunications carrier, reported better-than-expected earnings in the second quarter on strong results for...
Aug 07, 2023 (Gmt+09:00)
-
Banking & Finance
KB Kookmin Bank launches integrated bank in Cambodia
South Korea’s KB Kookmin Bank on Sunday said it received final approval on Friday from Cambodia’s Ministry of Commerce to launch the int...
Aug 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Corentec enters Japanese artificial joint market
Corentec Co., a South Korean company that develops artificial joints and spinal implants, is making a full-fledged entry into the Japanese market. T...
Jul 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Huons’ 2% lidocaine gets approval from FDA
South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Electronics
Galaxy Watch's alarm of abnormal heartbeat gets approval in S.Korea
Samsung Electronics Co.'s new feature on the Galaxy Watch, which detects heartbeats and alerts the possibility of risks such as arrhythmia, can now ...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.Geo-young on Tuesday said th...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Airlines
Korean Air says it can conclude Asiana takeover via big concessions
The head of Korean Air Lines Co. has expressed confidence over the airliner's proposed acquisition of Asiana Airlines, saying, "We will make it happ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins contract to build blood products plant in Indonesia
GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand